Background Approximately 50% of patients with metastatic urothelial cancer (UC) respond
to chemotherapy and several months of therapy is required to assess for radiographic …

OBJECTIVE: To examine the incidence and prognostic value of circulating tumor cells
(CTCs) in urothelial cancer (UC). The detection of CTCs is prognostic in several cancer …

What's known on the subject? and What does the study add? Circulating tumour cells (CTC)
have prognostic relevance for patients with different metastatic carcinomas. Detection of …

Objective To investigate circulating tumor cells (CTCs) as biomarkers of urothelial carcinoma
(UC). To date, the majority of work on this topic has utilized the CellSearch test, which has …

Background There are currently no methods in clinical use that can detect early systemic
dissemination of urothelial tumor cells. Objective To evaluate measurement of circulating …

BACKGROUND. Circulating tumor cells (CTCs) have been shown to aid in the therapeutic
management of patients. But, only a few attempts have been made at the detection of …

Objectives: To evaluate the relationship between circulating tumor cells (CTC) and clinical
parameters in metastatic urothelial cancer (UC). Methods: CTC were enumerated with the …

OBJECTIVE: Due to imprecise clinical staging, the finding of extravesical and node-positive
disease at the time of radical cystectomy (RC) for patients with clinically localized bladder …

ABSTRACT Background Circulating tumor cells (CTCs) provide prognostic information in
patients with metastatic tumors. Recent studies have shown that CTCs are released in …

Method: We include patients diagnosed with 3 types of urothelial tumours (prostate cancer,
urinary bladder cancer, and kidney cancer). A size-based separation method for viable CTC …